comparemela.com

Page 5 - Director Emer Cooke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

J&J Vaccine Gets Nod For Reapproval After Review Of Extremely Rare Blood Clots

Updated 17 hours ago J&J Vaccine Reapproved After Review Of ‘Extremely Rare’ Blood Clots A rare side effect, seen by 1.9 people per million doses given, forced the CDC and FDA to pause distribution of the COVID-19 vaccine last week. By Ryan Grenoble and Lydia O Connor Both the Food and Drug Administration and the Centers for Disease Control and Prevention ended their pause on the Johnson & Johnson COVID-19 vaccine on Friday after a panel of CDC advisers voted to recommend reapproval for the single-shot vaccine ― albeit with a new warning about extremely rare blood clots. The agencies concluded that the known benefits of the vaccine “outweigh its known and potential risks in individuals 18 years of age and older,” Acting FDA Commissioner Janet Woodcock said in a statement. “We are confident that this vaccine continues to meet our standards for safety, effectiveness and quality.”

J&J to resume EU vaccine shipments after review of clot risk

MONEYWEB LIVESTREAM Share rises as much as 2.9% on Tuesday. By Naomi Kresge, Bloomberg  21 Apr 2021  06:05  Image: Bloomberg Johnson & Johnson will restart deliveries of its Covid-19 vaccine to the European Union after the bloc’s drug regulator said the benefits of the shot outweigh the risks of a possible link with cases of rare blood clots. The European Medicines Agency assessment on Tuesday echoed its review of the vaccine from AstraZeneca, which has also been linked with the rare clot. In both cases, the regulator noted that Covid can be fatal and the use of vaccines is crucial to fighting the virus.

EU regulator finds possible link between Johnson & Johnson Covid vaccine and blood clots

EU regulator finds possible link between Johnson & Johnson Covid vaccine and blood clots The European Medicines Agency said the benefits of the jab far outweigh the very small risk of blood clots 20 April 2021 • 5:00pm The EMA said a warning about unusual blood clots should be added to the vaccine s labels as a very rare side effect Credit: Reuters The EU’s drug regulator has said there is a possible link between Johnson & Johnson s Covid-19 vaccine and rare blood clots. The European Medicines Agency (EMA) said a warning about unusual blood clots with low blood platelets should be added to the vaccine s labels as a very rare side effect of the single shot jab.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.